HYPERION DEFI, INC. Net Income (Loss) Available to Common Stockholders, Diluted
HYPERION DEFI, INC. (HYPD) reported Net Income (Loss) Available to Common Stockholders, Diluted of $15.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-13
- HYPERION DEFI, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was $15.73M.
- HYPERION DEFI, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $1.57M.
- HYPERION DEFI, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-06-30 was -$8.79M.
- HYPERION DEFI, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2024-09-30 was -$7.89M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|
| 2026-06-30 | $15.73M 10-Q · filed 2026-08-13 | $18.61M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.57M 10-Q · filed 2025-11-14 | -$7.21M derived: sum of 2 quarters · filed 2026-08-13 | -$6.44M 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$8.79M 10-Q · filed 2026-08-13 | -$12.27M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | -$7.89M 10-Q · filed 2025-11-14 | -$29.86M 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |